SBSusan M. Baxter

Susan M. Baxter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Susan M. Baxter has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 26 December 2008
      • Vol. 1, 132

    Management of High-Throughput DNA Sequencing Projects: Alpheus

    by Neil A. Miller, Stephen F. Kingsmore, Andrew Farmer, Raymond J. Langley, Joann Mudge, John A. Crow, Alvaro J. Gonzalez, Faye D. Schilkey, Ryan J. Kim, Jennifer Van Velkinburgh, et al.

    High-throughput DNA sequencing has enabled systems biology to begin to address areas in health, agricultural and basic biological research. Concomitant with the opportunities is an absolute necessity to manage significant volumes of high-dimensional and inter-related data and analysis. Alpheus is an analysis pipeline, database and visualization software for use with massively parallel DNA sequencing technologies that feature multi-gigabase throughput characterized by relatively short reads, such as Illumina-Solexa (sequencing-by-synthesis), Roche-454 (pyrosequencing) and Applied Biosystem’s SOLiD (sequencing-by-ligation). Alpheus enables alignment to reference sequence(s), detection of variants and enumeration of sequence abundance, including expression levels in transcriptome sequence. Alpheus is able to detect several types of variants, including non-synonymous and synonymous single nucleotide polymorphisms (SNPs), insertions/deletions (indels), premature stop codons, and splice isoforms. Variant detection is aided by the ability to filter variant calls based on consistency, expected allele frequency, sequence quality, coverage, and variant type in order to minimize false positives while maximizing the identification of true positives. Alpheus also enables comparisons of genes with variants between cases and controls or bulk segregant pools. Sequence-based differential expression comparisons can be developed, with data export to SAS JMP Genomics for statistical analysis.


  • Translational Bioinformatics: At the Interface of Genomics and Quantitative Genetics

    by William D. Beavis, Faye D. Schilkey, Susan M. Baxter

    Genomics and bioinformatics are expected to revolutionize crop improvement. We have to admit, however, that while information from the various “omics” is being used by developmental and evolutionary biologists, the information is not being used routinely by translational plant biologists or applied plant breeders. This is due to a failure to provide information from omics technologies in formats that can be used to develop more effective and efficient assays that the breeder can use for selection. A similar situation exists in biomedical research where more efficacious therapies will be realized if omics information is translated into biomarker‐based diagnostics. Because data are still lacking in plant science, herein we describe the development of an integrated web‐based system that supports translational research using a biomedical example that can serve as a model for translational plant research. We also discuss how the bioinformatic system is agnostic with respect to data content and is capable of accepting omics data that eventually will be generated by plant biologists for use by plant breeders to develop diagnostic biomarkers for use in selection.


  • Open Access

    Scientific Software Development Is Not an Oxymoron

    by Susan M. Baxter, Steven W. Day, Jacquelyn S. Fetrow, Stephanie J. Reisinger


  • Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets

    by Brian T. Hoffman, Melanie R. Nelson, Keith Burdick, Susan M. Baxter

    Abstract: The Protein Tyrosine Phosphatase (PTP) family contains not only several promising drug targets, such as PTP1B, but also proteins that are essential to cell development and survival. The availability of sequences and representative structures for the PTP family allows better identification of anti-targets, closely related family members likely to cross-react with directed inhibitors. Eight PTP subfamilies, classified by active site information and overall PTP catalytic domain structure similarity, are reviewed here: 1) the tyrosine-specific PTPs, 2) the dualspecificity PTPs, 3) the cdc25 subclass; 4) the Pten subclass; 5) the myotubularins, 6) the PRL subclass, 7) the low molecular weight PTPs, and 8) the newly defined cdc14 subclass. PTP subfamily classification and structure information can be incorporated into design strategies aimed at identifying potent and selective small molecule inhibitors. The accumulating inhibition data for compounds screened against panels of PTPs is reviewed. The in vitro data can yield clues to specificity so that individual subfamilies can be matched with effective scaffolds to jumpstart lead design and reduce false starts.


  • Open Access

    Synergistic Computational and Experimental Proteomics Approaches for More Accurate Detection of Active Serine Hydrolases in Yeast

    by Susan M. Baxter, Jonathan S. Rosenblum, Stacy Knutson, Melanie R. Nelson, Jennifer S. Montimurro, Jeannine A. Di Gennaro, Jeffrey A. Speir, Jonathan J. Burbaum, Jacquelyn S. Fetrow


  • Structure-based Active Site Profiles for Genome Analysis and Functional Family Subclassification

    by Stephen A. Cammer, Brian T. Hoffman, Jeffrey A. Speir, Mary A. Canady, Melanie R. Nelson, Stacy Knutson, Marijo Gallina, Susan M. Baxter, Jacquelyn S. Fetrow


  • Prediction of deleterious functional effects of amino acid mutations using a library of structure‐based function descriptors

    by Sanna Herrgard, Stephen A. Cammer, Brian T. Hoffman, Stacy Knutson, Marijo Gallina, Jeffrey A. Speir, Jacquelyn S. Fetrow, Susan M. Baxter

    An automated, active site‐focused, computational method is described for use in predicting the effects of engineered amino acid mutations on enzyme catalytic activity. The method uses structure‐based function descriptors (Fuzzy Functional Forms™ or FFFs™) to automatically identify enzyme functional sites in proteins. Three‐dimensional sequence profiles are created from the surrounding active site structure. The computationally derived active site profile is used to analyze the effect of each amino acid change by defining three key features: proximity of the change to the active site, degree of amino acid conservation at the position in related proteins, and compatibility of the change with residues observed at that position in similar proteins. The features were analyzed using a data set of individual amino acid mutations occurring at 128 residue positions in 14 different enzymes. The results show that changes at key active site residues and at highly conserved positions are likely to have deleterious effects on the catalytic activity, and that non‐conservative mutations at highly conserved residues are even more likely to be deleterious. Interestingly, the study revealed that amino acid substitutions at residues in close contact with the key active site residues are not more likely to have deleterious effects than mutations more distant from the active site. Utilization of the FFF‐derived structural information yields a prediction method that is accurate in 79–83% of the test cases. The success of this method across all six EC classes suggests that it can be used generally to predict the effects of mutations and nsSNPs for enzymes. Future applications of the approach include automated, large‐scale identification of deleterious nsSNPs in clinical populations and in large sets of disease‐associated nsSNPs, and identification of deleterious nsSNPs in drug targets and drug metabolizing enzymes. Proteins 2003.


  • Function first: a powerful approach to post-genomic drug discovery

    by Stephen F. Betz, Susan M. Baxter, Jacquelyn S. Fetrow


  • Engineered improvements in DNA-binding function of the MATa1 homeodomain reveal structural changes involved in combinatorial control

    by Beverly Hart, Jonathan R Mathias, David Ott, Lynn McNaughton, Janet S Anderson, Andrew K Vershon, Susan M Baxter


    • 1 May 2001
      • Vol. 4  (3) , 291-5

    Sequence- and structure-based protein function prediction from genomic information.

    by S M Baxter, J S Fetrow

    Existing functional annotation transfer is fraught with inaccuracies that may hinder forward interpretation and mining of genomic data. Hand-curation of the annotation placed into databases is not practical. In lieu of experimental evidence, computational biological approaches offer high-throughput tools to predict function accurately; however, these methods are still notably deficient in defining and describing the complexity of protein function. Enriching genomic sequences obtained from sequencing efforts and expression array methods with protein function information and classification will be an efficient first step for incorporating genomic data into drug discovery programs.